Keeping Track: Keytruda Claims First TMB-Based Cancer Indication; TG Therapeutics Submits First Umbralisib NDA

 
• By Bridget Silverman
  
Keeping Track Feature image
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers